Delivery Order SPE2DB22D2006-SPE2DB25FW0YG

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cefazolin 2 G/50 ML-Dextrose, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $1,187.46 and an ultimate completion date of May 23, 2024. The contract is a firm fixed-price delivery order and does not have a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,924,778 units of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The order has a ceiling value of $1,445.28 and is a firm fixed-price contract. The ultimate completion date for this delivery order is September 25, 2024. This award is not a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.08, is for the supply of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract is a Firm Fixed Price agreement with a period of performance through January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,550 units of the pharmaceutical product Cefazolin 2 g/50 mL-Dextroses. The contract, valued at $7,257.47, has an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,662,455 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract has a ceiling value of $15,175.44 and an ultimate completion date of September 4, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these essential medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.46, is for the delivery of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The contract has a firm fixed price pricing type and a completion date of November 22, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,577,305 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract has a firm fixed price of $2,195.20 and an ultimate completion date of May 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,529.24, is for the supply of Cefazolin 2 g/50 ml-Dextroses, a type of antibiotic medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cefazolin 2 g/50 mL-dextrose medication. The contract has a ceiling value of $2,123.62 and is a firm fixed-price delivery order that runs through August 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefazolin 2 g/50 ml-Dextroses. The contract has a total ceiling value of $2,112.53 and is a firm fixed price delivery order with an ultimate completion date of August 20, 2024. The contract was awarded on August 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0YG
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cefazolin 2 G/50 ML-Dextroses, with a ceiling value of $2,457.12 and a period of performance through May 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the company's broader IDC with the DLA, enabling the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/15/25, 9:58 AM